Glaxo: A History to 1962 - Definitive Corporate History

In this review the author R. P. T. Davenport-Hines with Judy Slinn presents a meticulous corporate history of Glaxo up to 1962 that will appeal to historians, business scholars and readers curious about the evolution of a global drug company. The book's biggest reason to buy is its unprecedented archival access, which allows the narrative to move beyond surface events into boardroom decisions, R&D choices and marketing strategies. The review focuses on how well the study explains Glaxo's growth, its research programs and the management choices that shaped a multinational.

Key Features

• Archival access: The account is based on unparalleled company records, providing primary evidence for key decisions and corporate turning points.
• Global scope: The book traces Glaxo's international operations, giving readers a clear sense of how a UK firm became a major multinational.
• R&D focus: Detailed treatment of research and development programs helps explain the scientific and commercial drivers behind product choices.
• Management and marketing: The narrative examines the company's marketing and management practices, illuminating how business strategy and promotion influenced growth.
• Product history: Descriptions of major products and their place in the company's portfolio show how product lines affected corporate direction.

Who It's For

This book is best for readers interested in economic history, business studies and the pharmaceutical industry, including students and academics seeking a well documented case study of corporate development. It also suits professionals wanting historical context for modern multinational pharma strategies.

Those looking for a light popular biography or a quick timeline should look elsewhere; the text is archival and analytical rather than anecdotal or brief, so casual readers may find the level of documentary detail dense.

Pros & Cons

Pros

• Well sourced narrative that draws on company archives to provide authoritative detail.
• Comprehensive coverage of global operations that clarifies how the firm expanded internationally.
• Substantive analysis of research, products and marketing that links science to business outcomes.

Cons

• Dense, archival style may feel heavy for readers expecting a brisk popular history.

Specifications

Title	Glaxo: A History to 1962
Authors	R. P. T. Davenport-Hines, Judy Slinn
Subject	Corporate history of a pharmaceutical company
Scope	Company origins to the year 1962
Focus areas	Global operations, R&D, products, marketing and management
Approach	Archival research and documentary analysis

Our Verdict

For scholars and professionals seeking a rigorous, well documented case study of a UK pharmaceutical multinational, this is a valuable and rewarding read. Its archival grounding and focus on research and corporate strategy make it good value for anyone wanting deep insight into how Glaxo grew and operated through 1962.

Frequently Asked Questions

Does this book cover Glaxo's product development?
The book examines research and development programs and discusses key products as part of the company's commercial history.

Is the narrative global in scope?
Yes; the study traces Glaxo's international operations and the company's evolution as a multinational firm.

Who wrote the book?
R. P. T. Davenport-Hines and Judy Slinn compiled the history using unprecedented access to company archives.